PCRX vs ABT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jan 31, 2026

PCRX

51.5
AI Score
VS
PCRX Wins

ABT

62.5
AI Score

Investment Advisor Scores

PCRX

52score
Recommendation
HOLD

ABT

63score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric PCRX ABT Winner
Forward P/E 5.7045 19.0476 PCRX
PEG Ratio -3.83 4.1675 Tie
Revenue Growth 6.5% 4.4% PCRX
Earnings Growth -47.8% -80.8% PCRX
Tradestie Score 51.5/100 62.5/100 ABT
Profit Margin 3.0% 14.7% ABT
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY ABT

Frequently Asked Questions

Based on our detailed analysis, PCRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.